Oral sodium and potassium binders in heart failure. - Wikidata - awgldk - TriplyDB

Oral sodium and potassium binders in heart failure.

Oral sodium and potassium binders in heart failure.

http://www.wikidata.org/entity/Q34455761

about

Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists.

P2860

Q38536675-4ACBF872-3157-4AF6-BD8F-3C7C6EE6C8ED

P2860

Oral sodium and potassium binders in heart failure.

http://www.wikidata.org/entity/Q34455761

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Oral sodium and potassium binders in heart failure.

@ast

Oral sodium and potassium binders in heart failure.

@en

Oral sodium and potassium binders in heart failure.

@nl

type

label

Oral sodium and potassium binders in heart failure.

@ast

Oral sodium and potassium binders in heart failure.

@en

Oral sodium and potassium binders in heart failure.

@nl

prefLabel

Oral sodium and potassium binders in heart failure.

@ast

Oral sodium and potassium binders in heart failure.

@en

Oral sodium and potassium binders in heart failure.

@nl

P1433

Q34455761-AD075BBE-B877-4407-B7BC-4F2FE2F48226

P1476

Q34455761-4071695B-92C3-489E-A415-B5569BE217F0

P2093

Q34455761-23A5D236-0925-440D-B743-5C7299D5356A

Q34455761-B7EEBADF-7F4C-4050-A4FC-CB385EB90455

Q34455761-E6FE06EE-01E6-43AB-80A5-13BC02CEEF49

P2860

Q34455761-0399DAAD-43CB-4169-840F-8D86DF2B7308

Q34455761-147CC5B4-E9E8-4050-85B3-EE689EB7A6D8

Q34455761-1C87A149-C7CA-4973-B245-7857ECB1D8A4

Q34455761-312BF0D0-B416-4DFA-9636-4AB4EF6E6352

Q34455761-4A7DEAB6-9AF4-4F5B-9B48-7D8F9AAB214E

Q34455761-5B53525E-9097-4D29-A3A1-14FE5266A0A4

Q34455761-5F9B0780-D0CD-4E53-A1D4-709F783C8581

Q34455761-75EE917D-CA23-4583-BAFB-11EB5311881F

Q34455761-7B6E031A-6419-4049-96F1-81DA67399C59

Q34455761-7FE1EB9F-0A85-4AD8-B626-94BEEC96EC6B

P2888

Q34455761-47C927CF-F29C-471C-B7D3-16B27F018E20

P304

Q34455761-E35FB320-06AA-4963-981E-0C3B92C8B84A

P31

Q34455761-B45F65C2-C51D-436D-A0B6-F8E5BDF35B14

P356

Q34455761-F558B122-9AFE-4C16-B0E0-7E1171790565

P433

Q34455761-5D6C8316-8B34-4B9C-A56E-6B6977401770

P478

Q34455761-13AF9BF5-D273-4992-ABA4-EB1F26C499EC

P50

Q34455761-BBC4DD2B-3821-4D78-B332-B83A6AD43156

P577

Q34455761-9C2D19FF-4E8B-4478-A930-067B669E68EE

P6179

Q34455761-E4B6A9C6-5C2F-47FB-AAAC-1D5ED6D173F0

P698

Q34455761-34D54171-625D-4695-B32B-86CE80AC4849

P356

S11897-014-0248-Y

P1433

Current heart failure reports

P1476

Oral sodium and potassium binders in heart failure.

@en

P2093

Alanna A Morris

http://www.w3.org/2001/XMLSchema#string

Divya Gupta

http://www.w3.org/2001/XMLSchema#string

Robert T Cole

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Hormones and hemodynamics in heart failure.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.

The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.

Diuretic strategies in patients with acute decompensated heart failure.

A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects

Dietary sodium intake in heart failure.

P2888

s11897-014-0248-y

P304

107-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-014-0248-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014917982

http://www.w3.org/2001/XMLSchema#string

P698

25542216

http://www.w3.org/2001/XMLSchema#string